Table 4.
Autoantibody | Outcome | Events | Hazard ratio (95% CI)* | ||||
---|---|---|---|---|---|---|---|
Men | Women | Men | Women | ||||
RF | MI, HF or PVD** | 313 | 558 | 1.46 (1.04, 2.04) | 1.14 (0.88, 1.46) | ||
Death | 382 | 616 | 1.31 (1.00, 1.71) | 1.56 (1.27, 1.92) | |||
ANA | MI, HF or PVD** | 310 | 580 | 1.40 (1.07, 1.82) | 1.22 (1.02, 1.45) | ||
Death | 475 | 667 | 1.17 (0.95, 1.44) | 1.20 (1.02, 1.41) |
Adjusted for age, calendar year, comorbidity, and presence of rheumatic disease
Defined as the first occurrence of any of the 3 events
RF = rheumatoid factor; ANA = antinuclear antibody; MI = myocardial infarction; HF = heart failure; PVD = peripheral vascular disease; HR = hazard ratio; CI = confidence interval; comorbidity = chronic disease comorbidities (9)